Skip to main content
. 2021 Mar 2;9:100115. doi: 10.1016/j.lanwpc.2021.100115

Table 2.

Pre-analytical, analytical and post-analytical issues identified in this study to address in implementing SARS-CoV-2 antigen testing.

Pre-analytical issues Pre-analytical solutions Analytical issues Analytical solutions Post-analytical issues Post-analytical solutions
Purpose Clearly define the purpose of testing, e.g., screening or diagnostic testing Quality control Perform negative and positive controls on new batches Waste Provide biohazardous waste disposal and ensure disposable antigen test devices are discarded appropriately
Target group Clearly define the appropriate population, e.g., based on symptoms or epidemiological risk factors Test validation Clearly identify the reference standard and the limitations of the reference standard Confirmation Define pathways to confirm positive results with RT-PCR, especially low-prevalence settings, when a positive result has higher likelihood of being false-positive
Resourcing Identify testing location, adequate space for registration, swabbing, donning/doffing and ensure resourcing of PPE/equipment Impact: Disease prevalence Understand the impact of the prevalence of disease on positive and negative predictive value of the test Exclusion Define pathways to perform RT-PCR if result is negative and clinical/ epidemiological suspicion remains high, especially in high-prevalence settings
Specimen collection Ensure staff are available and trained in PPE and infection control in addition to training staff in the use of novel diagnostic tests Impact: Assay characteristics Understand the sensitivity and specificity of the antigen assay in the target group of interest Reporting Communicate results in a timely and accurate manner, e.g., text message / telephone call if no cellular device
Leadership Ensure adequate clinical supervision is available to identify issues, escalate and communicate with key stakeholders Impact: Clinical characteristics Understand the performance on the test based on the clinical characteristics of the patient, e.g., duration of symptoms Quality assurance Consider role of external quality assurance program and incorporate into quality management system
Data management Ensure data is captured, accurate, confidential and stored securely (e.g., photograph result of lateral flow Ag assay) Impact: Public health Consider public health implications in the context of above, e.g., false negative result in aged care worker
Specimen handling Handle all specimens using appropriate PPE and consider testing as close to patient as feasible to reduce transport needs